Neurotec Pharma proposes integrated and innovative involving diagnostic and treatment for Brain Ischemia, the third death cause in occidenal world, after Cancer and Cardiovascular diseases.

This solutions offer significative advantatges respect to commercially available treatments at present. Some of them are:

This treatment is effective even 24 hours after injury, in comparison with the few hours for the other treatments available.

The secondary effects are totally negligible

It offers a universal solution: contrasting to the other treatments commercially available, all patients can benefit from our solutions. No incompatibilities, no contraindications.

Very low cost effectiveness: the cost of the production is very low, contrasting with the very high effectiveness of the treatment.

It also proposes new aproaches to treat acute and chronic Central Nervous System inflamation, which apear universally with aging and in all neurodegenerative diseases, as well as in chronic diseases injuring the Central Nervous System like Multiple Sclerosis, Meningitis or AIDS.

The principal advantatge of this solution is the susbstantial reduction of secondary effects with respect to the treatments commercially available. This is specially important in long-term treatments that are involved in this kind of diseases.

In the medium term, the company deals to propose and develop new solutions for the molecular diagnostic, monitoring and treatment of Central Nervous System diseases.